Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Azithromycin and Artesunate in Pregnant Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* peripheral malaria parasitemia~* signed informed consent~* age 15-49 years~* mother has felt the movements of the foetus (quickening)~* fetal age of at least 14 but not more than 26 completed gestation weeks~* maternal availability for follow-up during the entire period of the study~Exclusion Criteria:~* known maternal tuberculosis, diabetes, kidney disease, or liver disease~* mental disorder that may affect comprehension of the study or success of follow-up~* twin pregnancy~* pregnancy complications evident at enrollment visit (moderate to severe oedema, blood Hb concentration \< 7 g / dl, systolic blood pressure (BP) \> 160 mmHg or diastolic BP \> 100 mmHg)~* prior receipt of azithromycin during current pregnancy~* receipt of any antimalarial within 28 days before enrollment~* known allergy to drugs containing sulfonamides, macrolides or pyrimethamine~* history of anaphylaxis~* history of any serious allergic reaction to any substance, requiring emergency medical care~* history of hepatitis or jaundice~* concurrent participation in any other clinical trial

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).